Cited by 23Liver physiology and pathologyMicroRNA in disease regulationTGF-β signaling in diseases

Knockdown of miR-23, miR-27, and miR-24 alters fetal liver development and blocks fibrosis in mice

Open access
Rogler, Charles E., Matarlo, Joe S., Kosmyna, Brian, Fulop, Daniel, Rogler, Leslie E.·2017·Gene Expression

Abstract

MicroRNAs (miRNAs) regulate cell fate selection and cellular differentiation. miRNAs of the miR23b polycistron (miR-23b, miR-27b, and miR-24) target components of the TGF-β signaling pathway and affect murine bile ductular and hepatocyte cell fate selection in vitro. Here we show that miR-23b polycistron miRNAs directly target murine Smad4, which is required for TGF-β signaling. Injection of antagomirs against these miRNAs directly into E16.5 murine fetuses caused increased cytokeratin expression in sinusoids and primitive ductular elements throughout the parenchyma of newborn mice. Similar antagomir injection in newborn mice increased bile ductular differentiation in the liver periphery and reduced hepatocyte proliferation. Antagomir injection in newborn Alb/TGF-β1 transgenic mice that develop fibrosis inhibited the development of fibrosis, and injection of older mice caused the resolution of existing fibrosis. Furthermore, murine stellate cell activation, including ColA1 and ACTA2 expression, is regulated by miR-23b cluster miRNAs. In summary, knockdown of miR-23b cluster miRNAs in fetal and newborn liver promotes bile duct differentiation and can block or revert TGF-β-induced liver fibrosis that is dependent on stellate cell activation. These data may find practical application in the highly needed development of therapies for the treatment of fibrosis.

Integrity signals

Registry

Crossref · 10.3727/105221616x693891

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Functional studies in mice identified the miR-23 functional cluster as a regulator of liver fibrosis.

    “The functional studies in mice of different ages have identified the miR-23 functional cluster as a regulator of liver fibrosis.”
  • Direct injection of exogenous miR-23-27-24 cluster-specific inhibitor (antagomirs) into neonatal mice promoted bile duct differentiation and reduced hepatocyte proliferation.

    “direct injection of exogenous miR-23-27-24 cluster-specific inhibitor (named antagomirs) into neonatal mice promoted bile duct differentiation and reduced hepatocyte proliferation.”
  • Antagomirs can inhibit fibrosis development in newborn Alb/TGF-β1 transgenic mice, while injection in old mice restored existing fibrosis.

    “Antagomirs can inhibit fibrosis development in newborn Alb/TGF-β1 transgenic mice, while injection in old mice restored the existing fibrosis [17].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rogler, C. E., Matarlo, J. S., Kosmyna, B., Fulop, D., & Rogler, L. E.
Affiliations
Albert Einstein College of Medicine (US)
Venue
Gene Expression
Published
2017-02-10
Volume
17
Issue
2
Pages
99-114
ISSN
1052-2166 (ISSN-L)
OpenAlex
W2563094638
Cited by
23
References
54
Citations by year
2026: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 1
FWCI
2.17
Type
journal article
Language
en
Open access
Locations
  • Gene Expression (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (R01CA037232)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK041296)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
miR-23b, miR-27b, miR-24, fetal liver development, liver fibrosis, TGF-beta signaling, SMAD4, hepatocyte proliferation, stellate cell activation, cytokeratin, hepatocyte differentiation
MeSH terms
Actins, Animals, Bile Ducts, Cell Differentiation, Cell Line, Liver, Liver Cirrhosis, Mice, Inbred C57BL, Mice, Transgenic, Hepatocytes, MicroRNAs, Organogenesis, Fetal Development, Cell Proliferation, Mice, Transforming Growth Factor beta1, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review